Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AstraZeneca PLC - American Depositary Shares
(NY:
AZN
)
193.40
+5.39 (+2.87%)
Official Closing Price
Updated: 7:00 PM EST, Feb 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,726,808
Open
194.02
Bid (Size)
191.90 (200)
Ask (Size)
195.00 (100)
Prev. Close
188.01
Today's Range
190.60 - 195.90
52wk Range
183.63 - 195.90
Shares Outstanding
N/A
Dividend Yield
0.48%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
On February 10, 2026, AstraZeneca (NYSE:AZN) delivered an earnings report that did more than just recap a successful fiscal year; it laid down a definitive challenge to the current titans of the...
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Date: February 10, 2026 Introduction For years, Gilead Sciences, Inc. (Nasdaq: GILD) was characterized by investors as a "value trap"—a cash-rich biopharma giant that had lost its way after the...
Via
Finterra
Topics
Economy
Intellectual Property
Performance
YTD
+2.6%
+2.6%
1 Month
+2.6%
+2.6%
3 Month
+2.6%
+2.6%
6 Month
+2.6%
+2.6%
1 Year
+2.6%
+2.6%
More News
Read More
The $80 Billion Ambition: An In-Depth Analysis of AstraZeneca (AZN) in 2026
February 10, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Fraud
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
February 10, 2026
Via
FinancialNewsMedia
AstraZeneca results: FY and Q4 2025
February 10, 2026
From
AstraZeneca
Via
Business Wire
AstraZeneca’s Strategic Takeover of Modella AI Signals the Rise of Agentic Oncology
February 06, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
The Phoenix of Big Pharma: A 2026 Deep-Dive into AstraZeneca’s Global Dominance
February 06, 2026
Via
Finterra
Topics
Economy
Government
Intellectual Property
Trade War 2.0: 25% Tariffs on Chips, Cars, and Medicine Reshape the Global Supply Chain
February 05, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
OAK Family Advisors Sells $4 Million of NICE Stock
↗
February 05, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy
February 03, 2026
From
AstraZeneca
Via
Business Wire
US Trade Deficit Widens to -$56.8 Billion: A Surprise Drag on GDP Amid AI Infrastructure Surge
February 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Frequently Asked Questions
Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the New York Stock Exchange
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the New York Stock Exchange
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 193.40
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 02/10/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.